Phase 1 High cholesterol trials recruiting now

All High cholesterol trials, every phase

Other phases for High cholesterol

Phase 1 High cholesterol trials

• A Phase 1b Study to Evaluate the PK of CSL300 (Clazakizumab) in Chinese Subjects With End Stage Kidney Disease (ESKD)
  NCT07619820 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• A Safety and Tolerability Trial Evaluating CTX310 in Participants With Refractory Dyslipidemias
  NCT07491172 · Phase: Phase 1 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 17 locations
• A Study of BEBT-701 in Patients With Mild to Moderate Hypertension and Elevated Low-Density Lipoprotein Cholesterol（LDL-C）
  NCT07368608 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 60 Years · Sex: All (male and female) · 2 locations
• A Study of STX-1150 in Participants With Elevated Low-Density Lipoprotein Cholesterol (LDL-C)
  NCT07428473 · Phase: Phase 1 · Ages: 18 Years to 70 Years · Sex: All (male and female) · 2 locations
• A Study of VERVE-102 in Patients With Familial Hypercholesterolemia or Premature Coronary Artery Disease
  NCT06164730 · Phase: Phase 1 · Ages: 18 Years to 70 Years · Sex: All (male and female) · 27 locations
• A Study to Compare PK Characteristics and Safety Profiles Between AD-228B and AD-2284
  NCT06884098 · Phase: Phase 1 · Ages: 19 Years and older · Sex: All (male and female) · 1 location
• A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD4954 in Healthy Adult Participants With or Without Elevated Lipoprotein (a) (Lp[a]) Levels, and Participants With Dyslipidemia
  NCT06980428 · Phase: Phase 1 · Ages: 18 Years to 70 Years · Sex: All (male and female) · 6 locations
• Assessment of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of a New Formulation of Inclisiran Containing Polysorbate 80 Compared to the Currently Marketed Formulation
  NCT07626281 · Phase: Phase 1 · Ages: 18 Years to 60 Years · Sex: All (male and female) · 3 locations
• Phase 1a Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RN5681 in Healthy Volunteers
  NCT07347678 · Phase: Phase 1 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 2 locations
• Phase 1b Study of VERVE-201 in Patients With Refractory Hyperlipidemia
  NCT06451770 · Phase: Phase 1 · Ages: 18 Years to 70 Years · Sex: All (male and female) · 16 locations

Common questions

What does Phase 1 mean?

See how clinical trials work.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.